Feb. 28 is Rare Disease Day and Channel 9 is spotlighting a local family working to shed light on rare diseases all year long.

There’s currently no cure. “So, Ataxia-Telangiectasia is similar in ways to muscular dystrophy, meaning it’s a neuromuscular progressive disorder. So over time, around the age of seven ...

Macular telangiectasia, sometimes referred to as idiopathic juxtafoveal macular telangiectasia, is a disease that affects the part of the eye called the macula, causing degradation or loss of central ...

(NASDAQ:CDXC) today announced fourth quarter and fiscal year 2024 financial results. Fourth Quarter 2024. Total net s ...

The FDA approved revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for the treatment of macular telangiectasia type 2 (MacTel), a neurodegenerative disease of the retina causing ...

Macular telangiectasia type 2 (MacTel) is a vision-threatening, progressive, neurodegenerative disease of the retina that often leads to irreversible central vision loss. Before this month ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. Hereditary haemorrhagic telangiectasia (HHT, Rendu-Osler-Weber syndrome) exemplifies an ...

explore the immune profiles of patients with ataxia telangiectasia (AT), revealing deficiencies in T- and NK-cell function. These findings suggest therapeutic potential in targeting cytokine pathways ...